Cargando…
Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
COVID-19 caused by SARS-CoV-2 has raised a health crisis worldwide. The high morbidity and mortality associated with COVID-19 and the lack of effective drugs or vaccines for SARS-CoV-2 emphasize the urgent need for standard treatment and prophylaxis of COVID-19. The receptor-binding domain (RBD) of...
Autores principales: | Liu, Xiao-Huan, Cheng, Ting, Liu, Bao-Yu, Chi, Jia, Shu, Ting, Wang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395726/ https://www.ncbi.nlm.nih.gov/pubmed/36016554 http://dx.doi.org/10.3389/fphar.2022.955648 |
Ejemplares similares
-
Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants
por: Raghu, Deepa, et al.
Publicado: (2022) -
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020) -
Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV
por: Shen, Shuo, et al.
Publicado: (2007) -
Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
por: Henderson, Rory, et al.
Publicado: (2020) -
Controlling the SARS-CoV-2 spike glycoprotein conformation
por: Henderson, Rory, et al.
Publicado: (2020)